Aktiesnakken — December 2009
-
Hehe, er der ikke en lov imod det?
-
et eller andet sted, er det jo bare positivt, det var da værrer hvis abbott var ligeglad med ngal
-
og de heterogene tests... altså bio skal ha 4-5% royalties,
-
hej unge mand
-
sort humor frabedes
-
hvad mener stengaard
-
det er dig selv der har startet den:)
-
Hey Stengård...
-
bare gas.. men vi savner dig i debatten
-
Mit sum-up. Phadia er null and void. Abbott og BioSite må give sig, og alt går som planlagt...
-
Det er mit umiddelbare indtryk af sagens øjebliksbillede....
-
samme her.. men ville gerne lige have det til en side..
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind